Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Hypermobile Ehlers-Danlos Syndrome: A Tertiary Care Center Experience.
dysmotility
ehlers-danlos syndrome
fibromyalgia
irritable bowel syndrome
postural orthostatic tachycardia syndrome
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
29 Apr 2020
29 Apr 2020
Historique:
entrez:
4
6
2020
pubmed:
4
6
2020
medline:
4
6
2020
Statut:
epublish
Résumé
Introduction Ehlers-Danlos syndrome (EDS), specifically the hypermobility type (hEDS), is associated with a variety of gastrointestinal (GI) conditions. This study aims to evaluate the prevalence of and factors associated with gut dysmotility in patients with hEDS. Methods This is a retrospective study of hEDS patients conducted at the Cleveland Clinic's Center for Personalized Genetic Healthcare between January 2007 and December 2017. Demographics, GI motility testing, endoscopic, and imaging data were extracted from the patients' charts. Results A total of 218 patients with hEDS were identified. Among them, 136 (62.3%) patients had at least one GI symptom at the time of EDS diagnosis. Motility testing was performed and reported in 42 (19.2%) patients. Out of them, five (11.9%) had esophageal dysmotility, 18 (42.8%) had gastroparesis, five (11.9%) had small bowel/colon altered transit time, and four (9.5%) had global dysmotility. In univariable analysis, patients with postural orthostatic tachycardia syndrome (POTS) [odds ratio (OR): 8.88, 95% CI: 3.69-24.9, p<0.0001], fibromyalgia (OR: 4.43, 95% CI: 2.04-10.1, p=0.0002), history of irritable bowel syndrome (OR: 5.01, 95% CI: 2.31-11.2, p<0.0001), and gastroesophageal reflux disease (OR: 3.33, 95% CI: 1.55-7.44, p=0.002) were more likely to be diagnosed with GI dysmotility. On multivariable analysis, only POTS (OR: 5.74, 95% CI: 2.25-16.7, p=0.0005) was significantly associated with an increased likelihood of GI dysmotility. Conclusions This study suggests that GI symptoms are relatively common among patients with hEDS. Of the patients tested for dysmotility, 76.2% were found to have some form of dysmotility. POTS was found to be an independent predictive factor for GI dysmotility.
Identifiants
pubmed: 32489735
doi: 10.7759/cureus.7881
pmc: PMC7255528
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e7881Informations de copyright
Copyright © 2020, Alomari et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Neurogastroenterol Motil. 2015 Apr;27(4):569-79
pubmed: 25817057
Neurogastroenterol Motil. 2010 Mar;22(3):252-e78
pubmed: 19840271
Neurogastroenterol Motil. 2015 Jan;27(1):92-8
pubmed: 25483980
Control Clin Trials. 1996 Aug;17(4):343-6
pubmed: 8889347
Br J Haematol. 2004 Dec;127(5):491-500
pubmed: 15566352
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):181-187
pubmed: 28186368
Am J Med Genet A. 2010 Mar;152A(3):556-64
pubmed: 20140961
Am J Med Genet. 1998 Apr 28;77(1):31-7
pubmed: 9557891
Int Urogynecol J Pelvic Floor Dysfunct. 2003 Jun;14(2):128-32
pubmed: 12851757
Rheumatology (Oxford). 2005 Jun;44(6):744-50
pubmed: 15728418
Best Pract Res Clin Rheumatol. 2008 Mar;22(1):165-89
pubmed: 18328988
Adv Exp Med Biol. 2010;686:223-50
pubmed: 20824449
Clin Genet. 2012 Jul;82(1):1-11
pubmed: 22353005
Neurogastroenterol Motil. 2010 Oct;22(10):1085-e283
pubmed: 20618831
Rheumatology (Oxford). 2007 Dec;46(12):1835-41
pubmed: 18006569
Am J Med Genet C Semin Med Genet. 2015 Mar;169C(1):54-75
pubmed: 25821092
Ann Neurol. 2010 Jan;67(1):145-6; author reply 146-7
pubmed: 20186845
Vasc Endovascular Surg. 2002 May-Jun;36(3):213-7
pubmed: 12075387
Clin Exp Rheumatol. 2011 Nov-Dec;29(6):998-1005
pubmed: 22208933
Neurology. 1993 Jan;43(1):132-7
pubmed: 8423877
Rheumatology (Oxford). 2004 Sep;43(9):1194-5
pubmed: 15317957
Bull Acad Natl Med. 2012 Feb;196(2):393-404
pubmed: 23420959
Gastroenterol Res Pract. 2009;2009:924138
pubmed: 20169104
Clin Gastroenterol Hepatol. 2014 Oct;12(10):1680-87.e2
pubmed: 24440216
Neurogastroenterol Motil. 2015 Nov;27(11):1657-66
pubmed: 26376608
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26
pubmed: 28306229
Neurogastroenterol Motil. 2017 Sep;29(9):
pubmed: 28568908
Ann Rheum Dis. 1973 Sep;32(5):413-8
pubmed: 4751776